Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar timing with concurrent chemoradiotherapy in stage III NSCLC assessed by MRI functional imaging
ChiCTR-TRC-11001703Phase 3Completed
- Sponsor
- Shandong Cancer Hospital
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of endostar in non-small cell lung cancer (NSCLC) (3 arms), sponsored by Shandong Cancer Hospital. Primary endpoints: Survival and Short-term efficacy. Started Jun 2011; status: completed.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ChiCTR-TRC-11001703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001703.